Adaptive Clinical Trial Design

Ready to discuss a project?

Schedule a meeting with a statistical consultant today

Adaptive.pngCytel brings its expertise in adaptive designs to the design and implementation of the industry’s most innovative clinical trials. These highly flexible trials raise peculiar challenges for enrollment, data collection and regulatory submission. Why not have the industry leaders in adaptive design working on your adaptive trials?

Browse these snapshot case studies and learn how to apply adaptive trials in your setting.

Adaptive Confirmatory Examples


Article: Are Adaptive Trials the Answer to Oncology Development Success?

Yannis Jemiai, Senior VP at Cytel examines how adaptive clinical trials can help address oncology clinical development challenges by saving time, resources and improving the odds of success.

Download the article

FDA Guidance: Adaptive Design Clinical Trials for Drugs and Biologics

The FDA’s 2010 “Guidance for Industry Adaptive Design Clinical Trials for Drugs and Biologics” provides information regarding adaptive design clinical trials when used in drug development programs.

Read the guidance

Webinar: How can Program-Level Simulations Help to Optimize Phase 2 Trial Designs?

Jim Bolognese of Cytel and Narinder Nangia of Alkermes share how Phase 2 sample size can be optimized to yield maximum eNPV when 1 or 2 doses could be selected for Phase 3.

Click to play

Arrange Consulting